{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T04:27:22Z","timestamp":1786595242979,"version":"build-2736575974"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T00:00:00Z","timestamp":1779321600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T00:00:00Z","timestamp":1786579200000},"content-version":"vor","delay-in-days":84,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82460488"],"award-info":[{"award-number":["82460488"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373907"],"award-info":[{"award-number":["82373907"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004608","name":"Natural Science Foundation of Jiangsu Province","doi-asserted-by":"publisher","award":["BK20250101"],"award-info":[{"award-number":["BK20250101"]}],"id":[{"id":"10.13039\/501100004608","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biol Toxicol"],"DOI":"10.1007\/s10565-026-10211-1","type":"journal-article","created":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T14:47:15Z","timestamp":1779374835000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["ARF6 promotes the nuclear translocation of \u03b2-catenin to facilitate AFP deficiency-mediated metastasis in CTNNB1S33Y-mutant hepatocellular carcinoma"],"prefix":"10.1007","volume":"42","author":[{"given":"Ruitian","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longxuan","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyi","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinglong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Di","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libin","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,21]]},"reference":[{"key":"10211_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12834-1","volume":"7","author":"DS Bai","year":"2017","unstructured":"Bai DS, Zhang C, Chen P, Jin SJ, Jiang GQ. The prognostic correlation of AFP level at diagnosis with pathological grade, progression, and survival of patients with hepatocellular carcinoma. Sci Rep. 2017;7:12870. https:\/\/doi.org\/10.1038\/s41598-017-12834-1.","journal-title":"Sci Rep"},{"key":"10211_CR2","doi-asserted-by":"publisher","first-page":"394","DOI":"10.3322\/caac.21492","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394\u2013424. https:\/\/doi.org\/10.3322\/caac.21492.","journal-title":"CA Cancer J Clin"},{"key":"10211_CR3","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"10211_CR4","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/nm.4438","volume":"23","author":"L Broutier","year":"2017","unstructured":"Broutier L, Mastrogiovanni G, Verstegen MM, Francies HE, Gavarr\u00f3 LM, Bradshaw CR, et al. Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med. 2017;23:1424\u201335. https:\/\/doi.org\/10.1038\/nm.4438.","journal-title":"Nat Med"},{"key":"10211_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-12-86","volume":"12","author":"LH Butterfield","year":"2014","unstructured":"Butterfield LH, Economou JS, Gamblin TC, Geller DA. Alpha fetoprotein DNA prime and adenovirus boost immunization of two hepatocellular cancer patients. J Transl Med. 2014;12:86. https:\/\/doi.org\/10.1186\/1479-5876-12-86.","journal-title":"J Transl Med"},{"key":"10211_CR6","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2017.05.014","volume":"67","author":"J Calderaro","year":"2017","unstructured":"Calderaro J, Couchy G, Imbeaud S, Amaddeo G, Letouz\u00e9 E, Blanc JF, et al. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification. J Hepatol. 2017;67:727\u201338. https:\/\/doi.org\/10.1016\/j.jhep.2017.05.014.","journal-title":"J Hepatol"},{"key":"10211_CR7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.yexcr.2019.03.005","volume":"378","author":"Y Chen","year":"2019","unstructured":"Chen Y, Wen H, Zhou C, Su Q, Lin Y, Xie Y, et al. TNF-\u03b1 derived from M2 tumor-associated macrophages promotes epithelial-mesenchymal transition and cancer stemness through the Wnt\/\u03b2-catenin pathway in SMMC-7721 hepatocellular carcinoma cells. Exp Cell Res. 2019;378:41\u201350. https:\/\/doi.org\/10.1016\/j.yexcr.2019.03.005.","journal-title":"Exp Cell Res"},{"key":"10211_CR8","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1038\/s41388-019-1068-z","volume":"39","author":"MJF Crupi","year":"2020","unstructured":"Crupi MJF, Maritan SM, Reyes-Alvarez E, Lian EY, Hyndman BD, Rekab AN, et al. GGA3-mediated recycling of the RET receptor tyrosine kinase contributes to cell migration and invasion. Oncogene. 2020;39:1361\u201377. https:\/\/doi.org\/10.1038\/s41388-019-1068-z.","journal-title":"Oncogene"},{"key":"10211_CR9","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1038\/s41416-024-02849-7","volume":"131","author":"C Dantzer","year":"2024","unstructured":"Dantzer C, Dif L, Vache J, Basbous S, Billottet C, Moreau V. Specific features of \u00df-catenin-mutated hepatocellular carcinomas. Br J Cancer. 2024;131:1871\u201380. https:\/\/doi.org\/10.1038\/s41416-024-02849-7.","journal-title":"Br J Cancer"},{"key":"10211_CR10","doi-asserted-by":"publisher","first-page":"8847","DOI":"10.1073\/pnas.95.15.8847","volume":"95","author":"A de La Coste","year":"1998","unstructured":"de La Coste A, Romagnolo B, Billuart P, Renard CA, Buendia MA, Soubrane O, et al. Somatic mutations of the \u03b2-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci U S A. 1998;95:8847\u201351. https:\/\/doi.org\/10.1073\/pnas.95.15.8847.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10211_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1126\/science.7855600","volume":"267","author":"C D'Souza-Schorey","year":"1995","unstructured":"D\u2019Souza-Schorey C, Li G, Colombo MI, Stahl PD. A regulatory role for ARF6 in receptor-mediated endocytosis. Science. 1995;267:1175\u20138. https:\/\/doi.org\/10.1126\/science.7855600.","journal-title":"Science"},{"key":"10211_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrm1910","volume":"7","author":"C D'Souza-Schorey","year":"2006","unstructured":"D\u2019Souza-Schorey C, Chavrier P. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol. 2006;7:347\u201358. https:\/\/doi.org\/10.1038\/nrm1910.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10211_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-24968-y","volume":"12","author":"J Giubilaro","year":"2021","unstructured":"Giubilaro J, Schuetz DA, Stepniewski TM, Namkung Y, Khoury E, Lara-M\u00e1rquez M, et al. Discovery of a dual Ras and ARF6 inhibitor from a GPCR endocytosis screen. Nat Commun. 2021;12:4688. https:\/\/doi.org\/10.1038\/s41467-021-24968-y.","journal-title":"Nat Commun"},{"key":"10211_CR14","doi-asserted-by":"publisher","first-page":"6969","DOI":"10.1158\/0008-5472.CAN-08-1322","volume":"68","author":"RW Groen","year":"2008","unstructured":"Groen RW, Oud ME, Schilder-Tol EJ, Overdijk MB, ten Berge D, Nusse R, et al. Illegitimate WNT pathway activation by beta-catenin mutation or autocrine stimulation in T-cell malignancies. Cancer Res. 2008;68:6969\u201377. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1322.","journal-title":"Cancer Res"},{"key":"10211_CR15","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2003398","volume":"6","author":"AH Grossmann","year":"2013","unstructured":"Grossmann AH, Yoo JH, Clancy J, Sorensen LK, Sedgwick A, Tong Z, et al. The small GTPase ARF6 stimulates \u03b2-Catenin transcriptional activity during WNT5A-mediated melanoma invasion and metastasis. Science Signaling. 2013;6:ra14. https:\/\/doi.org\/10.1126\/scisignal.2003398.","journal-title":"Science Signaling"},{"key":"10211_CR16","doi-asserted-by":"publisher","DOI":"10.1177\/10732748241293680","volume":"31","author":"YA Idrissi","year":"2024","unstructured":"Idrissi YA, Rajabi MR, Beumer JH, Monga SP, Saeed A. Exploring the impact of the \u03b2-Catenin mutations in hepatocellular carcinoma: an in-depth review. Cancer Control. 2024;31:10732748241293680. https:\/\/doi.org\/10.1177\/10732748241293680.","journal-title":"Cancer Control"},{"key":"10211_CR17","doi-asserted-by":"publisher","first-page":"8","DOI":"10.14348\/molcells.2018.0436","volume":"42","author":"S Kim","year":"2019","unstructured":"Kim S, Jeong S. Mutation hotspots in the \u03b2-Catenin gene: lessons from the human cancer genome databases. Mol Cells. 2019;42:8\u201316. https:\/\/doi.org\/10.14348\/molcells.2018.0436.","journal-title":"Mol Cells"},{"key":"10211_CR18","doi-asserted-by":"publisher","unstructured":"Krishna A, Meynert A, Dolt KS, Kelder M, Mesropian A, Ewing A, Brouwers C, Claassens JW, Linssen MM, Sheraz S, Taylor GC, Gautier P, Ferrer-Vaquer A, Grimes G, Becher H, Silk R, Gris-Oliver A, Pinyol R, Semple CA, Kendall TJ, Bird TG, Hadjantonakis AK, Marsh JA, Llovet JM, Hohenstein P, Wood AJ, Ozdemir DD. Mutational scanning reveals oncogenic mutations have diverse effects on signaling. Nat Genet. 2026;58. https:\/\/doi.org\/10.1038\/s41588-025-02496-5.","DOI":"10.1038\/s41588-025-02496-5"},{"key":"10211_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/s0168-8278(99)80016-6","volume":"30","author":"T Kumada","year":"1999","unstructured":"Kumada T, Nakano S, Takeda I, Kiriyama S, Sone Y, Hayashi K, et al. Clinical utility of Lens culinaris agglutinin-reactive Alpha-fetoprotein in small hepatocellular carcinoma: special reference to imaging diagnosis. J Hepatol. 1999;30:125\u201330. https:\/\/doi.org\/10.1016\/s0168-8278(99)80016-6.","journal-title":"J Hepatol"},{"key":"10211_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1038\/s41575-025-01127-y","volume":"23","author":"BM Lehrich","year":"2026","unstructured":"Lehrich BM, Monga SP. WNT-beta-catenin signalling in hepatocellular carcinoma: from bench to clinical trials. Nat Rev Gastroenterol Hepatol. 2026;23:246\u201363. https:\/\/doi.org\/10.1038\/s41575-025-01127-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10211_CR21","doi-asserted-by":"publisher","first-page":"819","DOI":"10.3748\/wjg.v10.i6.819","volume":"10","author":"MS Li","year":"2004","unstructured":"Li MS, Li PF, Chen Q, Du GG, Li G. Alpha-fetoprotein stimulated the expression of some oncogenes in human hepatocellular carcinoma Bel 7402 cells. World J Gastroenterol. 2004;10:819\u201324. https:\/\/doi.org\/10.3748\/wjg.v10.i6.819.","journal-title":"World J Gastroenterol"},{"key":"10211_CR22","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1002\/ijc.25373","volume":"128","author":"M Li","year":"2011","unstructured":"Li M, Li H, Li C, Wang S, Jiang W, Liu Z, et al. Alpha-fetoprotein: a new member of intracellular signal molecules in regulation of the PI3K\/AKT signaling in human hepatoma cell lines. Int J Cancer. 2011;128:524\u201332. https:\/\/doi.org\/10.1002\/ijc.25373.","journal-title":"Int J Cancer"},{"key":"10211_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/j.lfs.2017.06.008","volume":"182","author":"R Li","year":"2017","unstructured":"Li R, Peng C, Zhang X, Wu Y, Pan S, Xiao Y. Roles of Arf6 in cancer cell invasion, metastasis and proliferation. Life Sci. 2017;182:80\u20134. https:\/\/doi.org\/10.1016\/j.lfs.2017.06.008.","journal-title":"Life Sci"},{"key":"10211_CR24","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/9327512","volume":"2020","author":"QT Li","year":"2020","unstructured":"Li QT, Qiu MJ, Yang SL, Fang X, He XX, Wang MM, et al. Alpha-Fetoprotein regulates the expression of immune-related proteins through the NF-\u03baB (P65) pathway in hepatocellular carcinoma cells. J Oncol. 2020;2020:9327512. https:\/\/doi.org\/10.1155\/2020\/9327512.","journal-title":"J Oncol"},{"key":"10211_CR25","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/jcmm.12745","volume":"20","author":"Y Lu","year":"2016","unstructured":"Lu Y, Zhu M, Li W, Lin B, Dong X, Chen Y, et al. Alpha fetoprotein plays a critical role in promoting metastasis of hepatocellular carcinoma cells. J Cell Mol Med. 2016;20:549\u201358. https:\/\/doi.org\/10.1111\/jcmm.12745.","journal-title":"J Cell Mol Med"},{"key":"10211_CR26","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s10549-005-9067-x","volume":"96","author":"PD Ottewell","year":"2006","unstructured":"Ottewell PD, Coleman RE, Holen I. From genetic abnormality to metastases: murine models of breast cancer and their use in the development of anticancer therapies. Breast Cancer Res Treat. 2006;96:101\u201313. https:\/\/doi.org\/10.1007\/s10549-005-9067-x.","journal-title":"Breast Cancer Res Treat"},{"key":"10211_CR27","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.devcel.2011.05.007","volume":"20","author":"CA Parachoniak","year":"2011","unstructured":"Parachoniak CA, Luo Y, Abella JV, Keen JH, Park M. GGA3 functions as a switch to promote Met receptor recycling, essential for sustained ERK and cell migration. Dev Cell. 2011;20:751\u201363. https:\/\/doi.org\/10.1016\/j.devcel.2011.05.007.","journal-title":"Dev Cell"},{"key":"10211_CR28","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1128\/mcb.01698-12","volume":"33","author":"O Pellon-Cardenas","year":"2013","unstructured":"Pellon-Cardenas O, Clancy J, Uwimpuhwe H, D\u2019Souza-Schorey C. ARF6-regulated endocytosis of growth factor receptors links cadherin-based adhesion to canonical Wnt signaling in epithelia. Mol Cell Biol. 2013;33:2963\u201375. https:\/\/doi.org\/10.1128\/mcb.01698-12.","journal-title":"Mol Cell Biol"},{"key":"10211_CR29","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1016\/j.jhep.2013.07.001","volume":"59","author":"F Pez","year":"2013","unstructured":"Pez F, Lopez A, Kim M, Wands JR, Caron de Fromentel C, Merle P. Wnt signaling and hepatocarcinogenesis: molecular targets for the development of innovative anticancer drugs. J Hepatol. 2013;59:1107\u201317. https:\/\/doi.org\/10.1016\/j.jhep.2013.07.001.","journal-title":"J Hepatol"},{"key":"10211_CR30","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00432-004-0572-9","volume":"130","author":"LX Qin","year":"2004","unstructured":"Qin LX, Tang ZY. Recent progress in predictive biomarkers for metastatic recurrence of human hepatocellular carcinoma: a review of the literature. J Cancer Res Clin Oncol. 2004;130:497\u2013513. https:\/\/doi.org\/10.1007\/s00432-004-0572-9.","journal-title":"J Cancer Res Clin Oncol"},{"key":"10211_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.ccell.2019.07.001","volume":"36","author":"Z Qiu","year":"2019","unstructured":"Qiu Z, Li H, Zhang Z, Zhu Z, He S, Wang X, et al. A pharmacogenomic landscape in human liver cancers. Cancer Cell. 2019;36:179-93.e11. https:\/\/doi.org\/10.1016\/j.ccell.2019.07.001.","journal-title":"Cancer Cell"},{"key":"10211_CR32","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1002\/hep.28638","volume":"64","author":"S Rebouissou","year":"2016","unstructured":"Rebouissou S, Franconi A, Calderaro J, Letouze E, Imbeaud S, Pilati C, et al. Genotype\u2010phenotype correlation of CTNNB1 mutations reveals different \u00df\u2010catenin activity associated with liver tumor progression. Hepatology. 2016;64:2047\u201361. https:\/\/doi.org\/10.1002\/hep.28638.","journal-title":"Hepatology"},{"key":"10211_CR33","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.4049\/jimmunol.1901080","volume":"204","author":"C Ren","year":"2020","unstructured":"Ren C, Yuan Q, Jian X, Randazzo PA, Tang W, Wu D. Small GTPase ARF6 is a coincidence-detection code for RPH3A polarization in neutrophil polarization. J Immunol. 2020;204:1012\u201321. https:\/\/doi.org\/10.4049\/jimmunol.1901080.","journal-title":"J Immunol"},{"key":"10211_CR34","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1038\/s41417-024-00764-w","volume":"31","author":"F Safri","year":"2024","unstructured":"Safri F, Nguyen R, Zerehpooshnesfchi S, George J, Qiao L. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Ther. 2024;31:1105\u201312. https:\/\/doi.org\/10.1038\/s41417-024-00764-w.","journal-title":"Cancer Gene Ther"},{"key":"10211_CR35","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1038\/ng.3252","volume":"47","author":"K Schulze","year":"2015","unstructured":"Schulze K, Imbeaud S, Letouz\u00e9 E, Alexandrov LB, Calderaro J, Rebouissou S, et al. Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets. Nat Genet. 2015;47:505\u201311. https:\/\/doi.org\/10.1038\/ng.3252.","journal-title":"Nat Genet"},{"key":"10211_CR36","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.semcdb.2010.09.002","volume":"22","author":"JK Schweitzer","year":"2011","unstructured":"Schweitzer JK, Sedgwick AE, D\u2019Souza-Schorey C. ARF6-mediated endocytic recycling impacts cell movement, cell division and lipid homeostasis. Semin Cell Dev Biol. 2011;22:39\u201347. https:\/\/doi.org\/10.1016\/j.semcdb.2010.09.002.","journal-title":"Semin Cell Dev Biol"},{"key":"10211_CR37","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000218013","volume":"18","author":"LN Semenkova","year":"1997","unstructured":"Semenkova LN, Dudich EI, Dudich IV, Shingarova LN, Korobko VG. Alpha-fetoprotein as a TNF resistance factor for the human hepatocarcinoma cell line HepG2. Tumour Biol. 1997;18:30\u201340. https:\/\/doi.org\/10.1159\/000218013.","journal-title":"Tumour Biol"},{"key":"10211_CR38","doi-asserted-by":"publisher","first-page":"4089","DOI":"10.1016\/j.apsb.2023.06.008","volume":"13","author":"D Sun","year":"2023","unstructured":"Sun D, Guo Y, Tang P, Li H, Chen L. Arf6 as a therapeutic target: structure, mechanism, and inhibitors. Acta Pharm Sin B. 2023;13:4089\u2013104. https:\/\/doi.org\/10.1016\/j.apsb.2023.06.008.","journal-title":"Acta Pharm Sin B"},{"key":"10211_CR39","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/hep.28601","volume":"64","author":"J Tao","year":"2016","unstructured":"Tao J, Xu E, Zhao Y, Singh S, Li X, Couchy G, et al. Modeling a human hepatocellular carcinoma subset in mice through coexpression of met and point-mutant beta-catenin. Hepatology. 2016;64:1587\u2013605. https:\/\/doi.org\/10.1002\/hep.28601.","journal-title":"Hepatology"},{"key":"10211_CR40","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/s0143-4004(83)80019-8","volume":"4","author":"V Toder","year":"1983","unstructured":"Toder V, Blank M, Gold-Gefter L, Nebel L. The effect of alpha-fetoprotein on the growth of placental cells in vitro. Placenta. 1983;4:79\u201386. https:\/\/doi.org\/10.1016\/s0143-4004(83)80019-8.","journal-title":"Placenta"},{"key":"10211_CR41","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1124\/molpharm.121.000304","volume":"100","author":"R Wang","year":"2021","unstructured":"Wang R, Schneider S, Keppler OT, Li B, Rutz B, Ciotkowska A, et al. ADP ribosylation factor 6 promotes contraction and proliferation, suppresses apoptosis and is specifically inhibited by NAV2729 in prostate stromal cells. Mol Pharmacol. 2021;100:356\u201371. https:\/\/doi.org\/10.1124\/molpharm.121.000304.","journal-title":"Mol Pharmacol"},{"key":"10211_CR42","doi-asserted-by":"publisher","DOI":"10.1172\/jci154515","author":"C Xu","year":"2022","unstructured":"Xu C, Xu Z, Zhang Y, Evert M, Calvisi DF, Chen X. \u03b2-Catenin signaling in hepatocellular carcinoma. J Clin Investig. 2022. https:\/\/doi.org\/10.1172\/jci154515.","journal-title":"J Clin Investig"},{"key":"10211_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2023.216240","author":"Y Xu","year":"2023","unstructured":"Xu Y, Zhang X, Zhang R, Sun Y, Liu J, Luo C, et al. AFP deletion leads to anti-tumorigenic but pro-metastatic roles in liver cancers with concomitant CTNNB1 mutations. Cancer Lett. 2023. https:\/\/doi.org\/10.1016\/j.canlet.2023.216240.","journal-title":"Cancer Lett"},{"key":"10211_CR44","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.canlet.2008.06.017","volume":"271","author":"X Yang","year":"2008","unstructured":"Yang X, Zhang Y, Zhang L, Zhang L, Mao J. Silencing alpha-fetoprotein expression induces growth arrest and apoptosis in human hepatocellular cancer cell. Cancer Lett. 2008;271:281\u201393. https:\/\/doi.org\/10.1016\/j.canlet.2008.06.017.","journal-title":"Cancer Lett"},{"key":"10211_CR45","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.3892\/ijo.2017.3985","volume":"50","author":"Y Yang","year":"2017","unstructured":"Yang Y, Zhang N, Zhu J, Hong XT, Liu H, Ou YR, et al. Downregulated connexin32 promotes EMT through the Wnt\/\u03b2-catenin pathway by targeting Snail expression in hepatocellular carcinoma. Int J Oncol. 2017;50:1977\u201388. https:\/\/doi.org\/10.3892\/ijo.2017.3985.","journal-title":"Int J Oncol"},{"key":"10211_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16:589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10211_CR47","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.ccell.2016.04.015","volume":"29","author":"JH Yoo","year":"2016","unstructured":"Yoo JH, Shi DS, Grossmann AH, Sorensen LK, Tong Z, Mleynek TM, et al. ARF6 is an actionable node that orchestrates oncogenic GNAQ signaling in uveal melanoma. Cancer Cell. 2016;29:889\u2013904. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.015.","journal-title":"Cancer Cell"},{"key":"10211_CR48","doi-asserted-by":"publisher","first-page":"2892","DOI":"10.1158\/0008-5472.Can-18-3026","volume":"79","author":"JH Yoo","year":"2019","unstructured":"Yoo JH, Brady SW, Acosta-Alvarez L, Rogers A, Peng J, Sorensen LK, et al. The small GTPase ARF6 activates PI3K in melanoma to induce a prometastatic state. Cancer Res. 2019;79:2892\u2013908. https:\/\/doi.org\/10.1158\/0008-5472.Can-18-3026.","journal-title":"Cancer Res"},{"key":"10211_CR49","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.molonc.2015.10.007","volume":"10","author":"H Zhao","year":"2016","unstructured":"Zhao H, Ahirwar DK, Oghumu S, Wilkie T, Powell CA, Nasser MW, et al. Endothelial Robo4 suppresses breast cancer growth and metastasis through regulation of tumor angiogenesis. Mol Oncol. 2016;10:272\u201381. https:\/\/doi.org\/10.1016\/j.molonc.2015.10.007.","journal-title":"Mol Oncol"},{"key":"10211_CR50","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/256916","volume":"2015","author":"M Zhu","year":"2015","unstructured":"Zhu M, Lin B, Zhou P, Li M. Molecular analysis of AFP and HSA interactions with PTEN protein. BioMed Res Int. 2015;2015:256916. https:\/\/doi.org\/10.1155\/2015\/256916.","journal-title":"BioMed Res Int"}],"container-title":["Cell Biology and Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10565-026-10211-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10565-026-10211-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T03:36:46Z","timestamp":1786592206000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10565-026-10211-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,21]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["10211"],"URL":"https:\/\/doi.org\/10.1007\/s10565-026-10211-1","relation":{},"ISSN":["1573-6822"],"issn-type":[{"value":"1573-6822","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,21]]},"assertion":[{"value":"19 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All methods in this study were performed in accordance with the relevant guidelines and regulations. The animal experiments were approved by the Ethical Committees of China Pharmaceutical University (2024\u201303-035), and conducted in accordance with the Guide for the Care and Use of Laboratory Animals. This work did not involve human subjects.","order":1,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"102"}}